Further study is required to better understand the prognostic value of the “tonic contraction” phenomenon in DMD patients, and whether the longer-term consequences of the pharmacological mitigation of this phenomenon via PDE5 inhibition or other means are favorable with respect to progression of cardiac disease. Here, PDE5A is linked to Duchenne muscular dystrophy.